In end-stage lung disease, transplantation is sometimes the only viable therapeutic option, but organ availability is limited and rejection presents an additional challenge. Innovative research efforts in ...
Mar 08, 2014
4.5 / 5 (8) | 0
(Medical Xpress)—Researchers at the Translational Genomics Research Institute (TGen) have discovered a protein, Mcl-1, that helps enable one of the most common and deadly types of cancer to survive radiation and drug treatments.
Mar 04, 2014
3.7 / 5 (3) | 0